Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.06 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.064 | 0.7 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |